The Annals
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 20, No. 10, pp. 757-761.
© 1986 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rybak, M.
Right arrow Articles by Boike, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rybak, M.
Right arrow Articles by Boike, S.


Research Articles

Monitoring vancomycin therapy

MJ Rybak and SC Boike

Vancomycin is an effective and widely used antistaphylococcal antibiotic. Despite several decades of use, however, our knowledge of the toxicologic and pharmacokinetic properties of vancomycin remains incomplete. This review summarizes current information regarding the adverse reactions and pharmacokinetics of vancomycin. Although there have been reports of side effects with vancomycin, these effects tend to be infrequent, easily managed, and reversible. Several methods for adjustment of vancomycin therapy have been recommended. The relationship between serum concentrations of vancomycin and the occurrence of ototoxicity or nephrotoxicity has not been well established. However, because of large interpatient variations in pharmacokinetic parameters, it seems preferable to individualize vancomycin therapy based on serum concentration data.


This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
M. Rybak, B. Lomaestro, J. C. Rotschafer, R. Moellering Jr., W. Craig, M. Billeter, J. R. Dalovisio, and D. P. Levine
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Am. J. Health Syst. Pharm., January 1, 2009; 66(1): 82 - 98.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. S. Buelga, M. del Mar Fernandez de Gatta, E. V. Herrera, A. Dominguez-Gil, and M. J. Garcia
Population Pharmacokinetic Analysis of Vancomycin in Patients with Hematological Malignancies
Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4934 - 4941.
[Abstract] [Full Text] [PDF]


Home page
Home Health Care Management PracticeHome page
M. L. McPherson
Monitoring home IV antibiotic therapy
Home Health Care Management Practice, January 1, 1990; 2(4): 69 - 77.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1986 by Harvey Whitney Books Company.